1. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, et al. Complex structure and regulation of the p16 (MTS1) locus. Cancer Res 1995; 55: 2988–2994.
2. Lukas J, Aagaard L, Strauss M, Bartek J . Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 1995; 55: 4818–4823.
3. Liggett Jr WH, Sidransky D . Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998; 16: 1197–1206.
4. Geradts J, Kratzke RA, Niehans GA, Lincoln CE . Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995; 55: 6006–6011.
5. Geradts J, Hruban R, Schutte M, Kern S, Maynard R . Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene: a comparison of four commercial antibodies. Appl Immunohistochem Mol Morphol 2000; 81: 71–79.